Literature DB >> 27572460

Roles of microRNAs in HIV-1 Replication and Latency.

Binlian Sun, Rongge Yang, Massimo Mallardo1.   

Abstract

MicroRNAs (miRNAs) are non-coding RNA molecules, with sequence length of 19-24 nucleotides, which can induce mRNA degradation and regulate protein translation repression. Recently plenty of reports showed that miRNAs increase or decrease in the serum (circulating miRNAs) and in PBMC of Human immunodeficiency virus type 1 (HIV-1) infected individuals to affect the replication of HIV-1 through regulating HIV-1 proteins or HIV-1 replication related host factors. Many of miRNAs can suppress HIV-1 replication, but do not affect the integrated viral DNA. Low or no viral protein expression could result in a block of virus and its replication to induce HIV-1 latency, which is the great obstacle of the cure of HIV-1 infection. In the HIV-1 latency reservoir, the integrated provirus can reactivate under appropriate stimulus, which results in HIV-1 reproduction. Factors imply that cellular miRNAs may promote the establishment of HIV-1 latency. Further studies on the mechanisms of miRNAs affecting viral protein expression will provide new approaches to clear the viral reservoir.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572460     DOI: 10.2174/2211536605666160829123118

Source DB:  PubMed          Journal:  Microrna


  10 in total

1.  MMTV does not encode viral microRNAs but alters the levels of cancer-associated host microRNAs.

Authors:  Rodney P Kincaid; Neena G Panicker; Mary M Lozano; Christopher S Sullivan; Jaquelin P Dudley; Farah Mustafa
Journal:  Virology       Date:  2017-11-05       Impact factor: 3.616

Review 2.  Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.

Authors:  Guillaume Mousseau; Susana T Valente
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 3.  The Effect of miRNA Gene Regulation on HIV Disease.

Authors:  Romona Chinniah; Theolan Adimulam; Louansha Nandlal; Thilona Arumugam; Veron Ramsuran
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

4.  MicroRNAs and exosomes: key players in HIV pathogenesis.

Authors:  J Sadri Nahand; F Bokharaei-Salim; M Karimzadeh; M Moghoofei; S Karampoor; H R Mirzaei; A Tabibzadeh; A Jafari; A Ghaderi; Z Asemi; H Mirzaei; M R Hamblin
Journal:  HIV Med       Date:  2019-11-22       Impact factor: 3.180

5.  Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.

Authors:  Ashley I Heinson; Jeongmin Woo; Amey Mukim; Cory H White; Bastiaan Moesker; Alberto Bosque; Celsa A Spina; Christopher H Woelk; Ben D Macarthur; Nadejda Beliakova-Bethell
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-10       Impact factor: 2.205

6.  A Novel lncRNA, AK130181, Contributes to HIV-1 Latency by Regulating Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.

Authors:  Haiyu Li; Xiangbo Chi; Rong Li; Jing Ouyang; Yaokai Chen
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-29       Impact factor: 8.886

Review 7.  Lnc(ing)RNAs to the "shock and kill" strategy for HIV-1 cure.

Authors:  Saikat Boliar; David G Russell
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-10       Impact factor: 8.886

8.  The RNA surveillance proteins UPF1, UPF2 and SMG6 affect HIV-1 reactivation at a post-transcriptional level.

Authors:  Shringar Rao; Raquel Amorim; Meijuan Niu; Abdelkrim Temzi; Andrew J Mouland
Journal:  Retrovirology       Date:  2018-06-28       Impact factor: 4.602

9.  Macrophages exposed to HIV viral protein disrupt lung epithelial cell integrity and mitochondrial bioenergetics via exosomal microRNA shuttling.

Authors:  Zhihong Yuan; Jessica R Petree; F Eun-Hyung Lee; Xian Fan; Khalid Salaita; David M Guidot; Ruxana T Sadikot
Journal:  Cell Death Dis       Date:  2019-08-02       Impact factor: 8.469

10.  Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy.

Authors:  Irene Consuegra; Samanta Gasco; María Jesús Serramía; José Luis Jiménez; Maria Jose Mellado; María Ángeles Muñoz-Fernández
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.